Logo image of WELL-DB.CA

WELL HEALTH TECHNOLOGIES (WELL-DB.CA) Stock Price, Quote, News and Overview

TSX:WELL-DB - Toronto Stock Exchange - CA94947LAC69 - Currency: CAD

100.01  +0.01 (+0.01%)

Fundamental Rating

3

WELL-DB gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 14 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of WELL-DB have multiple concerns. WELL-DB is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

WELL-DB had negative earnings in the past year.
In the past year WELL-DB had a positive cash flow from operations.
In multiple years WELL-DB reported negative net income over the last 5 years.
Of the past 5 years WELL-DB 4 years had a positive operating cash flow.
WELL-DB.CA Yearly Net Income VS EBIT VS OCF VS FCFWELL-DB.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M

1.2 Ratios

With a Return On Assets value of -1.60%, WELL-DB perfoms like the industry average, outperforming 42.86% of the companies in the same industry.
WELL-DB has a Return On Equity (-3.48%) which is in line with its industry peers.
Industry RankSector Rank
ROA -1.6%
ROE -3.48%
ROIC N/A
ROA(3y)0.64%
ROA(5y)-0.59%
ROE(3y)1.32%
ROE(5y)-0.98%
ROIC(3y)N/A
ROIC(5y)N/A
WELL-DB.CA Yearly ROA, ROE, ROICWELL-DB.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 -1K

1.3 Margins

WELL-DB's Gross Margin of 38.51% is in line compared to the rest of the industry. WELL-DB outperforms 50.00% of its industry peers.
In the last couple of years the Gross Margin of WELL-DB has grown nicely.
WELL-DB does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 38.51%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.09%
GM growth 5Y3.31%
WELL-DB.CA Yearly Profit, Operating, Gross MarginsWELL-DB.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K

More info and screens

3

2. Health

2.1 Basic Checks

WELL-DB does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, WELL-DB has more shares outstanding
WELL-DB has more shares outstanding than it did 5 years ago.
WELL-DB has a better debt/assets ratio than last year.
WELL-DB.CA Yearly Shares OutstandingWELL-DB.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
WELL-DB.CA Yearly Total Debt VS Total AssetsWELL-DB.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

An Altman-Z score of 15.94 indicates that WELL-DB is not in any danger for bankruptcy at the moment.
WELL-DB has a better Altman-Z score (15.94) than 100.00% of its industry peers.
WELL-DB has a Debt/Equity ratio of 0.59. This is a neutral value indicating WELL-DB is somewhat dependend on debt financing.
The Debt to Equity ratio of WELL-DB (0.59) is better than 64.29% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF N/A
Altman-Z 15.94
ROIC/WACCN/A
WACC7.81%
WELL-DB.CA Yearly LT Debt VS Equity VS FCFWELL-DB.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

WELL-DB has a Current Ratio of 0.92. This is a bad value and indicates that WELL-DB is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of WELL-DB (0.92) is comparable to the rest of the industry.
WELL-DB has a Quick Ratio of 0.92. This is a bad value and indicates that WELL-DB is not financially healthy enough and could expect problems in meeting its short term obligations.
WELL-DB has a better Quick ratio (0.92) than 64.29% of its industry peers.
Industry RankSector Rank
Current Ratio 0.92
Quick Ratio 0.92
WELL-DB.CA Yearly Current Assets VS Current LiabilitesWELL-DB.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

5

3. Growth

3.1 Past

The earnings per share for WELL-DB have decreased strongly by -200.00% in the last year.
WELL-DB shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 17.19%.
The Revenue has been growing by 94.78% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-200%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-337.5%
Revenue 1Y (TTM)17.19%
Revenue growth 3Y44.9%
Revenue growth 5Y94.78%
Sales Q2Q%27.02%

3.2 Future

Based on estimates for the next years, WELL-DB will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.87% on average per year.
The Revenue is expected to grow by 15.85% on average over the next years. This is quite good.
EPS Next Y46.2%
EPS Next 2Y30.38%
EPS Next 3Y30.92%
EPS Next 5Y15.87%
Revenue Next Year40.99%
Revenue Next 2Y22.96%
Revenue Next 3Y17.8%
Revenue Next 5Y15.85%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
WELL-DB.CA Yearly Revenue VS EstimatesWELL-DB.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B
WELL-DB.CA Yearly EPS VS EstimatesWELL-DB.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.1 -0.1 0.2 -0.2 0.3

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for WELL-DB. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 392.20, which means the current valuation is very expensive for WELL-DB.
WELL-DB's Price/Forward Earnings is on the same level as the industry average.
WELL-DB's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 36.52.
Industry RankSector Rank
PE N/A
Fwd PE 392.2
WELL-DB.CA Price Earnings VS Forward Price EarningsWELL-DB.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 200 -200 -400 -600 -800

4.2 Price Multiples

71.43% of the companies in the same industry are cheaper than WELL-DB, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 592.58
WELL-DB.CA Per share dataWELL-DB.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 3

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as WELL-DB's earnings are expected to grow with 30.92% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y30.38%
EPS Next 3Y30.92%

More info and screens

0

5. Dividend

5.1 Amount

WELL-DB does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

WELL HEALTH TECHNOLOGIES

TSX:WELL-DB (7/17/2025, 7:00:00 PM)

100.01

+0.01 (+0.01%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)05-14 2025-05-14/bmo
Earnings (Next)08-07 2025-08-07
Inst Owners7.41%
Inst Owner ChangeN/A
Ins Owners8.56%
Ins Owner ChangeN/A
Market Cap25.32B
Analysts81.05
Price Target198.39 (98.37%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-661.05%
Min EPS beat(2)-1116.23%
Max EPS beat(2)-205.87%
EPS beat(4)1
Avg EPS beat(4)4130.26%
Min EPS beat(4)-3335.29%
Max EPS beat(4)21178.4%
EPS beat(8)2
Avg EPS beat(8)1642.24%
EPS beat(12)3
Avg EPS beat(12)973.71%
EPS beat(16)3
Avg EPS beat(16)622.27%
Revenue beat(2)1
Avg Revenue beat(2)-5.51%
Min Revenue beat(2)-12.61%
Max Revenue beat(2)1.59%
Revenue beat(4)2
Avg Revenue beat(4)-2.66%
Min Revenue beat(4)-12.61%
Max Revenue beat(4)1.59%
Revenue beat(8)4
Avg Revenue beat(8)-0.92%
Revenue beat(12)7
Avg Revenue beat(12)0.22%
Revenue beat(16)11
Avg Revenue beat(16)1.27%
PT rev (1m)0.92%
PT rev (3m)27.78%
EPS NQ rev (1m)14.29%
EPS NQ rev (3m)128.57%
EPS NY rev (1m)0%
EPS NY rev (3m)36.27%
Revenue NQ rev (1m)0.06%
Revenue NQ rev (3m)24.97%
Revenue NY rev (1m)0%
Revenue NY rev (3m)21.29%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 392.2
P/S 25.77
P/FCF N/A
P/OCF 2027.11
P/B 30.34
P/tB N/A
EV/EBITDA 592.58
EPS(TTM)-0.12
EYN/A
EPS(NY)0.26
Fwd EY0.25%
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)0.05
OCFY0.05%
SpS3.88
BVpS3.3
TBVpS-1.36
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.6%
ROE -3.48%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 38.51%
FCFM N/A
ROA(3y)0.64%
ROA(5y)-0.59%
ROE(3y)1.32%
ROE(5y)-0.98%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.09%
GM growth 5Y3.31%
F-Score3
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF N/A
Debt/EBITDA 11.42
Cap/Depr 26.64%
Cap/Sales 2.04%
Interest Coverage N/A
Cash Conversion 28.75%
Profit Quality N/A
Current Ratio 0.92
Quick Ratio 0.92
Altman-Z 15.94
F-Score3
WACC7.81%
ROIC/WACCN/A
Cap/Depr(3y)15.79%
Cap/Depr(5y)16.17%
Cap/Sales(3y)1.31%
Cap/Sales(5y)1.41%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-200%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-337.5%
EPS Next Y46.2%
EPS Next 2Y30.38%
EPS Next 3Y30.92%
EPS Next 5Y15.87%
Revenue 1Y (TTM)17.19%
Revenue growth 3Y44.9%
Revenue growth 5Y94.78%
Sales Q2Q%27.02%
Revenue Next Year40.99%
Revenue Next 2Y22.96%
Revenue Next 3Y17.8%
Revenue Next 5Y15.85%
EBIT growth 1Y-191.33%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year269.34%
EBIT Next 3Y60.62%
EBIT Next 5Y41.9%
FCF growth 1Y-110.3%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-84.54%
OCF growth 3Y-22.85%
OCF growth 5YN/A